Shi Guohui, Ni Linlin, Kong Xiaoni, Ren Rutong, Shi Xinyu, Xu Yang, Qu Zhizi, Zhou Honglei, Zhang Xiusheng
Medical school, Shandong Xiehe University, Jinan, China.
College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Pharmacol. 2025 Sep 1;16:1640365. doi: 10.3389/fphar.2025.1640365. eCollection 2025.
Caudatin is a C steroidal glycoside isolated from many species of the genus , has been utilized by traditional medicine to treat cancer and inflammation which is increasingly being considered a drug candidate because of the pharmacological activity it displays. This review provides a discussion of caudatin's structure-activity relationship (SAR), pharmacology, and therapeutic uses along with a synthesis of future challenges. Caudatin is a potent anti-cancer therapeutic that has been shown to modulate several important signaling pathways, which include but are not limited to: Wnt/β-catenin, NF-κB, and PI3K/AKT pathway, induce apoptosis through ROS mediated mitochondrial dysfunction, reduce metastatic spread through inhibition of epithelial-mesenchymal transition (EMT), and have an anti-inflammatory effect through inhibition of JNK/AP-1/NF-κB signaling. Caudatin has also displayed neuroprotection in models of Alzheimer's disease by activating TFEB and the autophagosome-lysosomal pathway mechanism of action, while also modulating PPARα. Furthermore, pharmacokinetic studies indicate that caudatin is rapidly absorbed and is able to selectively tail hepatic tissue while having little to no toxicity or significant adverse events in pre- clinical animal studies. Structure-activity studies suggest that modifications on the C-3 hydroxyl position, primarily with nitrogen heterocycles and/or sugars greatly enhance the bioactivity and solubility. With caudatin being such a great scaffold for medicinal chemistry, there is great opportunity to take advantage of caudatin as a building block to generate novel therapies which bridge traditional medicine with modern drug discovery. The future is aimed primarily at a combination strategy of synthetic derivatives, translational studies, and formulations. In further exploring caudatin as a treatment for cancer and neurodegenerative diseases, and inflammation.
考达汀是一种从多种[属名]植物中分离出的C甾体苷,传统医学一直用其治疗癌症和炎症,由于其显示出的药理活性,它越来越被视为一种候选药物。本综述讨论了考达汀的构效关系(SAR)、药理学和治疗用途,并综合了未来面临的挑战。考达汀是一种有效的抗癌治疗药物,已被证明可调节多种重要的信号通路,包括但不限于:Wnt/β-连环蛋白、NF-κB和PI3K/AKT通路,通过ROS介导的线粒体功能障碍诱导细胞凋亡,通过抑制上皮-间质转化(EMT)减少转移扩散,并通过抑制JNK/AP-1/NF-κB信号发挥抗炎作用。考达汀还通过激活TFEB和自噬体-溶酶体途径作用机制在阿尔茨海默病模型中显示出神经保护作用,同时还调节PPARα。此外,药代动力学研究表明,考达汀吸收迅速,能够选择性地靶向肝组织,而在临床前动物研究中几乎没有毒性或重大不良事件。构效关系研究表明,对C-3羟基位置进行修饰,主要是与氮杂环和/或糖类结合,可大大提高生物活性和溶解度。由于考达汀是药物化学的一个很好的骨架,有很大的机会利用考达汀作为构建模块来开发将传统医学与现代药物发现相结合的新型疗法。未来主要目标是合成衍生物、转化研究和制剂的联合策略,以进一步探索考达汀作为癌症、神经退行性疾病和炎症的治疗方法。